-
Medline Inc (MDLN) PT Raised to $55 at Evercore ISI
-
FDA: Medline has identified electrical safety risks with its Medline Basic Homecare beds that may lead to fire
-
Tigress Financial Partners Starts Medline Inc (MDLN) at Buy
-
Citi Starts Medline Inc (MDLN) at Sell
-
BNP Paribas Exane Starts Medline Inc (MDLN) at Neutral
-
Deutsche Bank Starts Medline Inc (MDLN) at Hold
-
Nephron Starts Medline Inc (MDLN) at Hold
-
Wells Fargo Starts Medline Inc (MDLN) at Equal Weight
-
BofA Securities Starts Medline Inc (MDLN) at Buy
-
BTIG Starts Medline Inc (MDLN) at Buy
-
Wolfe Research Starts Medline Inc (MDLN) at Outperform
-
TD Cowen Starts Medline Inc (MDLN) at Buy
-
William Blair Starts Medline Inc (MDLN) at Outperform
-
Mizuho Starts Medline Inc (MDLN) at Outperform
-
Medline’s $25 bln supply chain scale wins Jefferies “buy” in coverage debut
-
Barclays Starts Medline Inc (MDLN) at Overweight
-
Rothschild Redburn Starts Medline Inc (MDLN) at Neutral
-
Truist Securities Starts Medline Inc (MDLN) at Buy
-
Morgan Stanley Starts Medline Inc (MDLN) at Overweight
-
Jefferies Starts Medline Inc (MDLN) at Buy
-
BMO Capital Starts Medline Inc (MDLN) at Outperform
-
Stifel Starts Medline Inc (MDLN) at Buy
-
JPMorgan Starts Medline Inc (MDLN) at Overweight
-
UBS Starts Medline Inc (MDLN) at Buy
-
Baird Starts Medline Inc (MDLN) at Outperform
-
Evercore ISI Starts Medline Inc (MDLN) at Outperform
-
Piper Sandler Starts Medline Inc (MDLN) at Overweight
-
RBC Capital Starts Medline Inc (MDLN) at Outperform
-
Leerink Partners Starts Medline Inc (MDLN) at Outperform
-
Bernstein SocGen Group Starts Medline Inc (MDLN) at Outperform
-
Goldman Sachs Starts Medline Inc (MDLN) at Buy
-
Medline shares surge 21% in Nasdaq debut after largest IPO of 2025
-
Medline opens at $35/share, higher than IPO pricing at $29/share
-
Medline now indicating open above $33
-
Medline now indicating to open at $32.5, IPO priced at $29
-
Medline indicating open above $31, IPO priced at $29
-
Medline prices IPO at $29 per share
-
Medline Inc (MDLN) files for 179M share IPO at $26-$30/sh
-
Medline weighing the marketing of U.S. IPO as soon as Monday, Bloomberg reports
-
Healthcare giant Medline files to return to public markets via Nasdaq listing
-
Medline files for IPO with SEC, plans NASDAQ listing
-
Medline (MDLN) files for a proposed Nasdaq IPO

